On Dec. 1 - 2, those issues will come to the fore as national experts in genetics, medicine, law, big data and other fields gather for Frontiers in
Precision Medicine II:
Cancer, Big Data and the Public, a unique
precision medicine symposium at the University of Utah S.J. Quinney College of Law, Center for Law and Biomedical Sciences, University of Utah Health Sciences, Huntsman
Cancer Institute, and University of Utah Center for Excellence in ELSI Research (UCEER) addresses those topics as
precision medicine is gaining more attention nationwide from health
care systems, practitioners, researchers, insurers and federal agencies.
Two new
precision medicine tests that look beyond
cancer genes to identify novel therapeutic targets have just received New York State Department of Health approval and are now available to both oncologists and
cancer researchers for use at the front lines of patient
care.